Pamisell has ranked among the top searched stocks for 7 days in the past month.
As of 2:30 PM on the 16th, Pamisell is trading at 20,050 KRW, down 1.23% from the previous day. This represents an 11.67% decrease compared to August 26. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners have tentatively net purchased 18,966 shares. Over the past 5 days, individual investors have net sold 202,370 shares, while foreigners and institutions have net purchased 215,724 shares and net sold 24,424 shares, respectively.
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
